Tumor expansion and immune regulation in a mathematical model of cancer under variations in tumor cell proliferation rate and innate immune stimulation
Mathematical Biosciences and Engineering · 2025
DOI: 10.3934/mbe.2025104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathematical Biosciences and Engineering, 2025. Verfasst von Manuel Arturo Nova-Martínez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ingeniería, Grupo de Investigación Programas de Ingenierías (Grupo-GIPIS), Universidad Cooperativa de Colombia, Villavicencio 500001, Col…. Hauptthemen laut MEDLINE: Immunity, Innate, Neoplasms, Models, Immunological. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Facultad de Ingeniería, Grupo de Investigación Programas de Ingenierías (Grupo-GIPIS), Universidad Cooperativa de Colombia, Villavicencio 500001, Colombia.
- Departamento de Matemáticas y Estadística, Grupo de Matemáticas del Tolima (Grupo-MaT), Universidad del Tolima, Ibagué 730001, Colombia.
Zitieren
APA
Nova-Martínez, M. A., & Granada-Díaz, H. A. (2025). Tumor expansion and immune regulation in a mathematical model of cancer under variations in tumor cell proliferation rate and innate immune stimulation. Mathematical Biosciences and Engineering. https://doi.org/10.3934/mbe.2025104
Vancouver
Nova-Martínez MA, Granada-Díaz HA. Tumor expansion and immune regulation in a mathematical model of cancer under variations in tumor cell proliferation rate and innate immune stimulation. Mathematical Biosciences and Engineering. 2025. doi:10.3934/mbe.2025104
BibTeX
@article{NovaMartnez2025,
author = {Nova-Martínez, Manuel Arturo and Granada-Díaz, Héctor Andrés},
title = {Tumor expansion and immune regulation in a mathematical model of cancer under variations in tumor cell proliferation rate and innate immune stimulation},
journal = {Mathematical Biosciences and Engineering},
year = {2025},
doi = {10.3934/mbe.2025104}
}
EUVIMED